XML 40 R24.htm IDEA: XBRL DOCUMENT v3.25.3
SEGMENT INFORMATION (Tables)
9 Months Ended
Sep. 30, 2025
SEGMENT INFORMATION  
Schedule of Segment Information
b.Segment information:

Nine Months Ended September 30, 

Three Months Ended September 30, 

(U.S. dollars in thousands)

2025

2024

2025

2024

Revenues from customers

$

43,622

$

35,181

$

17,851

$

17,959

Less:

Employee salaries and related expenses

16,502

15,091

5,853

4,734

Sub-contractors expense

9,348

6,413

1,886

1,649

Interest expense

1,021

260

Interest income

(817)

(970)

(289)

(212)

Depreciation

1,078

970

372

329

Other segment expenses*

18,343

15,818

7,790

7,356

Income (loss) before taxes on income

(832)

(3,162)

2,239

3,843

Taxes on income (tax benefit)

268

400

(116)

607

Segment net income (loss)

$

(1,100)

$

(3,562)

$

2,355

$

3,236

* Other expenses included in net income includes raw materials, rent and utilities and others.

Schedule of Disaggregation of Revenues

c.The following table summarizes the Company’s disaggregation of revenues:

Nine Months Ended September 30, 

Three Months Ended September 30, 

(U.S. dollars in thousands)

2025

2024

    

2025

2024

Gaucher disease:

 

Pfizer (Ireland)

$

15,431

$

11,431

$

2,805

$

3,430

Fiocruz (Brazil)

$

9,121

$

9,314

$

6,105

$

2,048

Fabry disease:

Chiesi (Italy)

$

18,556

$

14,075

$

8,763

$

12,361

Total revenues from selling goods

$

43,108

$

34,820

$

17,673

$

17,839

Revenues from license and R&D services

$

514

$

361

$

178

$

120